BioNTech SE (BNTX) Cash from Investing Activities (2018 - 2025)

BioNTech SE has disclosed Cash from Investing Activities across 8 years of filings, most recently posting -$3.2 billion for Q4 2025.

• Cash from Investing Activities for Q4 2025 came in at -$3.2 billion, down 589.38% year-over-year; the trailing twelve-month figure through Dec 2025 was -$2.9 billion (down 29.47% YoY), and the FY2025 annual result was -$2.8 billion, down 25.4% from the prior year.
• Cash from Investing Activities came in at -$3.2 billion for Q4 2025 at BioNTech SE, down from $648.3 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $648.3 million in Q4 2024 to a low of -$3.2 billion in Q4 2025.
• The 5-year median for Cash from Investing Activities is -$208.0 million (2024), against an average of -$898.1 million.
• Across the five-year window, Cash from Investing Activities soared 96043426.27% in 2021 and sank 1865.35% in 2023, its largest moves.
• BioNTech SE's Cash from Investing Activities stood at $114.3 million in 2021, then surged by 43.73% to $164.3 million in 2022, then plunged by 1865.35% to -$2.9 billion in 2023, then jumped by 122.36% to $648.3 million in 2024, then tumbled by 589.38% to -$3.2 billion in 2025.
• The last three Cash from Investing Activities figures came in at -$3.2 billion (Q4 2025), $648.3 million (Q4 2024), and -$156.1 million (Q3 2024), per Business Quant data.